Founded in 2000, EyeGene Inc. is a South Korean biotechnology company specializing in the research and development of biopharmaceuticals targeting age-related diseases, particularly those affecting vision. The company's mission is to develop innovative therapeutics, diagnostics, and technologies for eye-related diseases.

Biopharmaceutical Development: EyeGene focuses on creating novel therapeutics and vaccines for various medical conditions, including ocular diseases and viral infections.

Private

Biotech